Skip to main content

Table 1 Clinical and demographic characteristics of type 2 diabetic participants and their relationships with levels of Ang-2 and Tie-2 after controlling for age and BMI

From: Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study

Parameters

Participants (n = 80)

p- value

Sex (%)

47.7 (female)

NS

Age (years)

65 ± 7

‡(r = -0.349, p < 0.002)

BMI (kg/m2)

32 ± 6

†(r = 0.277, p < 0.01)

Waist to height ratio

0.66 ± 0.12

NS

Duration of diabetes (years)

15 ± 9

NS

* Ang-2 (pg/ml)

2955 (1349-9000)

‡(r = 0.355, p < 0.002)

sTie-2 (ng/ml)

28.34 ± 7.58

†(r = 0.355, p < 0.002)

Active smokers (%)

23

NS

Therapy

 

†(p < 0.04)

Insulin therapy (%)

48.7

 

Oral anti-diabetic therapy (%)

51.3

 

Systolic blood pressure (mmHg)

145 ± 21

NS

Diastolic blood pressure (mmHg)

82 ± 14

†(r = -0.259, p < 0.02)

Diabetic retinopathy (%)

3.8

NS

Microalbuminuria (%)

3.8

NS

Polyneuropathy (%)

50

†(p < 0.01)

#Macro-vascular complications (%)

29.1

†(p < 0.009)

  1. Data are expressed as mean ± standard deviation or as percentage. (*): data not normally distributed, expressed as a median and range, and log10- transformed for analysis. (#): included cardiac, cerebral or peripheral vascular disease. (†): significantly associated with levels of Ang-2. (‡): significantly associated with levels of sTie-2. NS: not significant.